Tilray Brands stock price has plunged and moved into a bear market after falling by over 53% from its highest point this year ...

Curaleaf Holdings posts robust Q3 2025 results and rising international revenue. Learn about CURLF stock's growth outlook ...

Cannabis stocks are marching higher on reports that U.S. Medicare is considering covering CBD treatments for some patients, ...

Tilray stock price has attempted to rebound this week as it rose in the last three consecutive days. Here are top reasons it ...

Key Takeaways Tilray Brands shares tumbled Friday ahead of a 1-for-10 reverse stock split set set to take effect after markets close next Monday, Dec. 1. In a reverse stock split, a company cuts the ...

As of Friday, November 28, Tilray Brands, Inc.’s TLRY share price has dipped by 18.44%, which has investors questioning if ...

Trulieve Cannabis stock has seen its consensus analyst price target edge down slightly from $19.16 to $18.87 in recent market updates. While this change appears modest, it reflects a blend of cautious ...

Cannabis company Tilray Brands has become the center of Wall Street attention as shares rocketed 17.52% following reports that President Trump is considering reclassifying marijuana from its current ...

Trulieve Cannabis posts strong Q3 growth as a federal bill with a hemp THC ban adds uncertainty with shares down this year. See why TCNNF stock is a hold.

Once considered a darling of the cannabis sector, shares of Tilray Brands TLRY have steadily declined over the past few years due to regulatory hurdles and intensifying competition. After becoming one ...

Despite a declining share price over the last few years, Canada-based Aurora Cannabis ACB has staged a strong rally this year, all thanks to encouraging third-quarter fiscal 2025 (year ending March ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...